Still Awaiting Approval by Chinese Agencies, BGI-Shenzhen Extends Offer for Complete Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – BGI-Shenzhen said late on Wednesday that it has again extended its cash tender offer for Complete Genomics.

The offer is now set to expire midnight EST on Feb. 22. The extension is to allow China's Ministry of Commerce time to approve the deal and China's State Administration of Foreign Exchange to register the transaction, BGI said. It also noted the upcoming Chinese New Year holiday in China, which is set to begin Feb. 9 and end Feb. 15.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that Walgreens didn't fully vet Theranos before entering partnership.

Jeremy Berg is to be the next editor in chief of Science magazine.

Regeneron Pharmaceuticals is to be the new sponsor of the prestigious high school Science Talent Search competition, according to the New York Times.

In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.